Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Piccart, Martine"'
Autor:
Azim HA Jr; Cairo Cure Oncology Center, Cairo, Egypt.; Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico., Niman SM; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Demeestere I; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium.; Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium., Ruggeri M; Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan., Saetersdal AB; Breast Cancer Unit, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Dutch Breast Cancer Research Group (BOOG), Amsterdam, the Netherlands., Mailliez A; Breast Cancer Unit, Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Warner E; Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada.; Canadian Clinical Trials Group (CCTG), Toronto, ON, Canada., Borges VF; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO., Amant F; Department of Oncology, KU Leuven and Leuven Cancer Institute, Leuven, Belgium.; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.; Antoni van Leeuwenhoek-Netherlands Gynecologic Oncology Cancer Institute, Amsterdam, the Netherlands., Gombos A; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Kataoka A; Breast Oncology Cancer, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Centre, Centre Léon Bérard, Lyon, France., Borstnar S; Division of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia., Takei J; St Luke's International Hospital, Breast Center, Tokyo, Japan., Lee JE; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Department of Clinical Research and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea., Walshe JM; Cancer Trials Ireland, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Tallaght University Hospital, Dublin, Ireland., Ruíz-Borrego M; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Hospital Virgen del Rocio Sevilla, Sevilla, Spain., Moore HCF; Breast Oncology Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Saunders C; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Bjelic-Radisic V; Breast Unit, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany.; Medical University Graz, Department Gynaecology, Graz, Austria.; Austrian Breast and Colorectal Study Group (ABCSG), Vienna, Austria., Susnjar S; Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Klar NJ; New York University Langone's Perlmutter Cancer Center, Breast Cancer Center, New York, NY., Spanic T; Europa Donna, Ljubljana, Slovenia., Ruddy K; Department of Oncology, Mayo Clinic, Rochester, MN., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium., Korde LA; Breast and Melanoma Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Goldhirsch A; International Breast Cancer Study Group, Division of ETOP IBCSG Partners Foundation, Bern, Switzerland.; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Gelber RD; International Breast Cancer Study Group Statistical Center, Boston, MA.; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Frontier Science Foundation, Boston, MA.; Harvard TH Chan School of Public Health, Boston, MA., Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Peccatori FA; Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 10; Vol. 42 (23), pp. 2822-2832. Date of Electronic Publication: 2024 May 29.
Autor:
Alaeikhanehshir S; Division of Molecular Pathology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Ajayi T; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Duijnhoven FH; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Poncet C; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Olaniran RO; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Lips EH; Division of Molecular Pathology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van 't Veer LJ; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Delaloge S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Rubio IT; Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain., Thompson AM; Dan L Duncan Comprehensive Cancer Centre, Baylor College of Medicine, Houston, TX., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Piccart M; Department of Research, Jules Bordet Institute, Free University of Brussels, Brussels, Belgium., Rutgers EJT; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 01; Vol. 42 (10), pp. 1124-1134. Date of Electronic Publication: 2024 Jan 19.
Autor:
van Mackelenbergh MT; Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany., Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Geyer CE Jr; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Gianni L; San Raffaele Scientific Institute, Milan, Italy., Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France., Jackisch C; Sana Klinikum Offenbach GmbH, Offenbach, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., Tang G; University of Pittsburgh, Pittsburgh, PA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany., Rastogi P; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom., Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil., Wolmark N; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Cortazar P; Genentech, Inc, South San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2998-3008. Date of Electronic Publication: 2023 Apr 19.
Autor:
Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Loibl S; German Breast Group, Neu-Isenburg, Germany., van Mackelenbergh MT; German Breast Group, Neu-Isenburg, Germany., Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany., Rastogi P; NRG Oncology, Pittsburgh, PA., Gianni L; San Raffaele Scientific Institute, Milan, Italy., Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France., Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany., Nekljudova V; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Tang G; University of Pittsburgh, Pittsburgh, PA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany., Geyer CE Jr; UPMC Hillman Cancer Center, Pittsburgh, PA., Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom., Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil., Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, PA., Cortazar P; Genentech, Inc, South San Francisco, CA., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2988-2997. Date of Electronic Publication: 2023 Mar 28.
Autor:
Lopes Cardozo JMN; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Drukker CA; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rutgers EJT; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Glas AM; Agendia NV, Amsterdam, the Netherlands., Witteveen A; Agendia NV, Amsterdam, the Netherlands., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Esserman LJ; Department of Surgery, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., van 't Veer LJ; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 20; Vol. 40 (12), pp. 1335-1345. Date of Electronic Publication: 2022 Jan 21.
Autor:
Piccart M; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium., Procter M; Frontier Science Scotland Ltd, Kincraig, Kingussie, United Kingdom., Fumagalli D; Breast International Group (BIG), Brussels, Belgium., de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium., Clark E; Roche Products Limited, Welwyn Garden City, United Kingdom., Ewer MS; University of Texas, MD Anderson Cancer Center, Huston, TX., Restuccia E; Hoffmann-La Roche Ltd, Basel, Switzerland., Jerusalem G; CHU Liege and Liege University, Liege, Belgium., Dent S; Duke Cancer Institute, Duke University, Durham, NC., Reaby L; Inaugural Chair-Consumer Advisory Panel, Breast Cancer Trials Group, Newcastle, Australia.; Consumer Advisor to Breast Researchers, Garvan Institute of Research, Sydney, Australia., Bonnefoi H; Institute Bergonié, UNICANCER, University of Bordeaux, Bordeaux, France., Krop I; Dana-Farber Cancer Institute, Boston, MA., Liu TW; National Health Research Institutes, Taipei, Taiwan., Pieńkowski T; Oncological Department, Postgraduate Medical Education Center, Warsaw, Poland., Toi M; Breast Cancer Unit, Kyoto University Hospital, Kyoto, Japan., Wilcken N; Director of Medical Oncology, Westmead Hospital, Sydney.; Associate Professor of Medicine, University of Sydney, Sydney, Australia., Andersson M; Department of Oncology, Rigshospitalet, University Hospital, Copenhagen, Denmark.; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Im YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Tseng LM; Comprehensive Breast Health Center, Experimental Surgery, Department of Surgery, Taipei-Veterans General Hospital, Taipei, Taiwan., Lueck HJ; Gynäkologisch-Onkologische Praxis Hannover, Hannover, Germany., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Monturus E; Hoffmann-La Roche Ltd, Basel, Switzerland., Sicoe M; Breast International Group (BIG), Brussels, Belgium., Guillaume S; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium., Bines J; Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, MA., Viale G; University of Milan, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Thomssen C; Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 01; Vol. 39 (13), pp. 1448-1457. Date of Electronic Publication: 2021 Feb 04.
Autor:
Piccart MJ; Institut Jules Bordet, Department of Medicine, Brussels, Belgium., Hilbers FS; Breast International Group, Brussels, Belgium., Bliss JM; The Institute of Cancer Research, Clinical Trials & Statistics Unit, London, United Kingdom., Caballero C; Breast International Group, Brussels, Belgium., Frank ES; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA., Renault P; Patient advocate, Belgium., Naït Kaoudjt R; Patient advocate, France., Schumacher E; Mamma Mia! Das Brustkrebsmagazin, Kronberg, Germany., Spears PA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Regan MM; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gelber RD; International Breast Cancer Study Group Statistical Center, Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Harvard TH Chan School of Public Health, Boston, MA.; Frontier Science and Technology Research Foundation, Boston, MA., Davidson NE; Fred Hutchinson Cancer Research Center, Seattle, WA.; University of Washington, Seattle, WA., Norton L; Memorial Sloan Kettering Cancer Center, Department of Medicine, New York, NY., Winer EP; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Dec 01; Vol. 38 (34), pp. 4120-4129. Date of Electronic Publication: 2020 Oct 14.
Autor:
Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, Leuven, Belgium., Fornili M; Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Clatot F; Laboratory for Translational Breast Cancer Research, Department of Oncology, Leuven, Belgium.; Centre Henri Becquerel, Rouen, France., Demicheli R; Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., De Bortoli D; Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Di Leo A; Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Prato, Italy., Viale G; European Institute of Oncology, University of Milan, Milan, Italy., de Azambuja E; Breast European Adjuvant Study Team, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Crown J; St Vincent's University Hospital, Dublin, Ireland., Francis PA; Peter MacCallum Cancer Centre, St Vincent's Hospital, University of Melbourne, Australia; Breast Cancer Trials Australia and New Zealand, University of Newcastle, Australia., Sotiriou C; Breast Cancer Translational Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Biganzoli E; Unit of Medical Statistics, Biometry and Bioinformatics Giulio A. Maccacaro Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Sep 01; Vol. 38 (25), pp. 2883-2891. Date of Electronic Publication: 2020 Jul 02.
Autor:
Delaloge S; Gustave Roussy, Villejuif, France.; Unicancer Breast Group, Paris, France., Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Rutgers E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Litière S; European Organization for Research and Treatment of Cancer, Brussels, Belgium., van 't Veer LJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., van den Berkmortel F; Zuyderland Medisch Centrum, Heerlen-Geleen, the Netherlands., Brain E; Institut Curie-Hôpital Rene Huguenin, Saint-Cloud, France., Dudek-Peric A; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Gil-Gil M; Institut Catala D'Oncologia-Institut d'Investigacio Biomedica de Bellvitge, L'Hospitalet, Barcelona, Spain., Gomez P; Hospital General Vall D'Hebron, Barcelona, Spain., Hilbers FS; Breast International Group, Brussels, Belgium., Khalil Z; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Knox S; Europa Donna-The European Breast Cancer Coalition, Milan, Italy., Kuemmel S; Breast Unit Kliniken Essen-Mitte, Westdeutsche Studiengruppe, Mönchengladbach, Germany., Kunz G; St Johannes Hospital, Dortmund, Germany., Lesur A; Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy, France., Pierga JY; Institut Curie-Hôpital Rene Huguenin, Saint-Cloud, France.; Institut Curie Paris Sciences et Lettres, Université de Paris, Paris, France., Ravdin P; The University of Texas Health Sciences Center, San Antonio, TX., Rubio IT; Clinica Universidad de Navarra-Site Madrid, Madrid, Spain., Saghatchian M; Gustave Roussy, Villejuif, France., Smilde TJ; Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands., Thompson AM; Baylor University College of Medicine, Houston, TX., Viale G; University of Milan and European Institute of Oncology-Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy., Zoppoli G; University of Genoa and Azienda Ospedaliera Universitaria San Martino, Genova, Italy., Vuylsteke P; Centre Hospitalier Universitaire, Université Catholique de Louvain, Namur, Belgium., Tryfonidis K; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Poncet C; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Bogaerts J; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Cardoso F; Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 10; Vol. 38 (11), pp. 1186-1197. Date of Electronic Publication: 2020 Feb 21.
Autor:
Loi S; 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Drubay D; 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France.; 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France., Adams S; 4 New York University School of Medicine, New York, NY., Pruneri G; 5 Fondazione Istituto di Ricovero e Cura a Carattere Scientifico-Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy., Francis PA; 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Lacroix-Triki M; 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France., Joensuu H; 7 Helsinki University Central Hospital, Helsinki, Finland., Dieci MV; 8 University of Padova, Padova, Italy.; 9 Veneto Insitute of Oncology-IOV-IRCCS, Padua, Italy., Badve S; 10 Indiana University, Indianapolis, IN., Demaria S; 11 Weill-Cornell Medicine, New York, NY., Gray R; 12 Dana-Farber Cancer Institute, Boston, MA., Munzone E; 13 European institute of Oncology, Milan, Italy., Lemonnier J; 6 R&D UNICANCER, Paris, France., Sotiriou C; 14 Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium., Piccart MJ; 14 Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium., Kellokumpu-Lehtinen PL; 15 Tampere University Hospital, Tampere, Finland., Vingiani A; 16 University of Milan, Milan, Italy., Gray K; 12 Dana-Farber Cancer Institute, Boston, MA., Andre F; 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France.; 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France., Denkert C; 17 Charite Universite Hospital, Berlin, Germany., Salgado R; 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.; 18 GZA, Antwerp, Belgium., Michiels S; 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France.; 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Mar 01; Vol. 37 (7), pp. 559-569. Date of Electronic Publication: 2019 Jan 16.